These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24237054)

  • 1. Better protection for patentees: preliminary injunctions in the EU for pharmaceutical patent matters.
    von Falck A; Gundt M
    Pharm Pat Anal; 2013 May; 2(3):291-3. PubMed ID: 24237054
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary injunctions in generic and branded patent litigation.
    Cohen S; England P
    Expert Opin Ther Pat; 2013 Sep; 23(9):1083-6. PubMed ID: 23855903
    [No Abstract]   [Full Text] [Related]  

  • 3. European Commission targets drug firms over illegal patent protection.
    Watson R
    BMJ; 2010 Jan; 340():c268. PubMed ID: 20080819
    [No Abstract]   [Full Text] [Related]  

  • 4. Indian generic drug production. Benefits of EU-India free trade agreement.
    Ager B
    BMJ; 2011 Apr; 342():d2439. PubMed ID: 21502277
    [No Abstract]   [Full Text] [Related]  

  • 5. Canada ordered to implement WTO ruling against "stockpiling" of generic drugs.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2000; 5(4):27. PubMed ID: 11833161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The production of generic drugs in India.
    Love J
    BMJ; 2011 Mar; 342():d1694. PubMed ID: 21427048
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent injunctions in Europe: the return of the pan-European injunction--or how can you get a decision from one court effective in more than one country?
    Freeland R
    Pharm Pat Anal; 2015; 4(6):405-7. PubMed ID: 26580987
    [No Abstract]   [Full Text] [Related]  

  • 8. Patent litigation in India continues to throw up new challenges.
    Reddy Thikkavarapu P
    Pharm Pat Anal; 2016 Jul; 5(4):211-6. PubMed ID: 27348790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Similarity of biotechnology-derived drugs: regulatory framework and specificity].
    Prugnaud JL
    Ann Pharm Fr; 2008 Aug; 66(4):206-11. PubMed ID: 18847566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity.
    Morag-Sela T; Cohn I; Kowalski TJ; Jarecki-Black J; Clyde-Watson Z
    Nat Biotechnol; 2004 Dec; 22(12):1591-2. PubMed ID: 15583670
    [No Abstract]   [Full Text] [Related]  

  • 11. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274462
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug patent protection: how long is long enough?
    Sibbald B
    CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146
    [No Abstract]   [Full Text] [Related]  

  • 13. Patent. Battle lines are drawn over generic AIDS drug.
    AIDS Policy Law; 2005 Aug; 20(16):6. PubMed ID: 16161208
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent infringement. Generic HIV drugmaker's patent claim is time-barred.
    AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916
    [No Abstract]   [Full Text] [Related]  

  • 15. Long way down--pharmaceutical companies fear falling off 'patent cliff'.
    Sklan A
    Pharm Pat Anal; 2012 Jul; 1(3):240. PubMed ID: 24386667
    [No Abstract]   [Full Text] [Related]  

  • 16. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 17. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering.
    Paine CS
    Seton Hall Law Rev; 2003; 33(2):479-510. PubMed ID: 12715807
    [No Abstract]   [Full Text] [Related]  

  • 18. Protecting profits.
    Neroth P
    Lancet; 2004 Oct 2-8; 364(9441):1207-8. PubMed ID: 15470807
    [No Abstract]   [Full Text] [Related]  

  • 19. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 20. Patent quality.
    Sklan A
    Pharm Pat Anal; 2014 Jan; 3(1):17-24. PubMed ID: 24354975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.